Embecta (EMBC) reported fiscal Q4 adjusted earnings Tuesday of $0.45 per diluted share, down from $0.59 a year earlier.

Analysts polled by FactSet expected $0.36.

Revenue for the quarter ended Sept. 30 was $286.1 million, down from $281.9 million a year earlier.

Four analysts surveyed by FactSet expected $277 million

For fiscal 2025, the medical supplies company expects adjusted EPS of $2.70 to $2.90 on revenue of $1.09 billion to $1.11 billion. Analysts polled by FactSet expect non-GAAP EPS of $2.27 on revenue of $1.12 billion.